NunaBio Ltd. can provide large-scale production of a desired sequence of DNA to GLP grade. We can meet CRO and CMO needs with DNA at any scale.
Our unique approach produces high quality DNA which, unlike cf bacterial manufacturing platforms, has the following benefits:
- No bacterial or plasmid DNA contamination
- No antibiotic contamination
- No mitogen or protein contamination
- No endotoxin contamination from bacterial cells
- No hazardous solvent usage
We also have extensive experience in making modified DNA with enhanced properties and/or functionality for further chemistries/biological applications.
NunaBio offers a one stop solution of collaborative, novel DNA development to manufacturing. Potential uses for our products include components of in-vitro diagnostic tests, preclinical nucleic acid-based drugs, DNA vaccines, RNA therapies and gene therapies.